Press Releases 2012

09.05.2012

Epigenomics AG Announces Q1 2012 Financial Results and Operational Highlights

PDF 190 KB

11.04.2012

Epigenomics AG Enrolls First Participant in its FIT comparative study with Epi proColon®

PDF 65 KB

23.03.2012

Epigenomics AG: Full Year Results for the Year Ended 31 December 2011

PDF 92 KB

16.03.2012

Epigenomics AG Plans Changes in the Composition and Size of its Supervisory Board

PDF 128 KB

06.03.2012

Epigenomics AG: Study Shows Patient Preference for Blood Based Colorectal Cancer Screening

PDF 71 KB

16.02.2012

Epigenomics Septin9 Biomarker detects Colon Cancer equally in both sides of the Colon

PDF 70 KB

14.02.2012

Epigenomics’ Epi proLung® BL Assay shows Strong Performance as Confirmation Test for Lung Cancer Diagnosis

PDF 71 KB

05.01.2012

Epigenomics Biomarker Predicts Drug Resistance in Colorectal Cancer

PDF 69 KB

04.01.2012

Epigenomics announces initiation of PMA filing for Epi proColon, provides update on regulatory timeline

PDF 69 KB